Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalfurafine Hydrochloride OD Tablets for Refractory Pruritus in Chronic Liver Disease
CTR20231629Phase 3Active
- Sponsor
- Toray Industries
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of paroxetine in pruritus, sponsored by Toray Industries. Started May 2023; status: active.
02
Drugs
paroxetine
03
Conditions
pruritus
Beyond the preview
Go deeper on CTR20231629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231629.